Physician

Jeffery Scott Davis, APN RN

According to 2025 Medicare claims, Jeffery Davis, APN RN (NPI: 1639402738) practices nurse practitioner in the Paducah, KY-IL market, with the plurality of this provider's patient population coming from Massac, IL. This provider's primary affiliated billing organization is CLINICAL RESEARCH ASSOCIATES, PC (NPI: 1063632826; TIN: 431699473) and primary practice location at 62960-2700. Davis is affiliated with the IRCCO (ACO ID: A2619) and IHCI ACO Midwest LLC (ACO ID: A5516), participating under the MSSP model.

Davis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 65 traditional Medicare patients, billed 85 HCPCS/CPT codes, and received $5,189 in Medicare payments. The top billing code was 99309 (Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes). Part D data shows 2,731 prescription claims across 260 beneficiaries totaling $688,810 in drug costs, led by Austedo (Deutetrabenazine). Open Payments data shows 104 records totaling $12,391. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,706 to $688,810. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.0K$5.9K2022 Medicare payment: $2,288 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $5,907 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,189 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20223538$2,288
20236284$5,907
20246585$5,189

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$344K$689K2015 Drug cost: $1,706 (USD; Tot_Drug_Cst)2019 Drug cost: $1,163 (USD; Tot_Drug_Cst)2020 Drug cost: $1,564 (USD; Tot_Drug_Cst)2022 Drug cost: $34,108 (USD; Tot_Drug_Cst)2023 Drug cost: $199,722 (USD; Tot_Drug_Cst)2024 Drug cost: $688,810 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R50$1,706
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R13$1,163
2020N/R19$1,564
2021N/RN/RN/R
2022101426$34,108
20231641,284$199,722
20242602,731$688,810

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99309Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes1920$70
99308Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, 20 minutes or more3639$49

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
AustedoDeutetrabenazine361,027$184,541
IngrezzaValbenazine Tosylate24627$178,532
RexultiBrexpiprazole831,330$72,509
Austedo XrDeutetrabenazine11330$65,091
Invega SustennaPaliperidone Palmitate14400$41,771

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.104$12,391Teva Pharmaceuticals USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jeffery Scott Davis, APN RN?

Tedicare shows public-source Medicare data for Jeffery Scott Davis, APN RN (NPI 1639402738), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffery Scott Davis, APN RN have ACO affiliation data?

Jeffery Scott Davis, APN RN is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619) and IHCI ACO Midwest LLC (MSSP, ACO ID A5516).

What billing organization is linked to Jeffery Scott Davis, APN RN?

Jeffery Scott Davis, APN RN is linked to CLINICAL RESEARCH ASSOCIATES, PC (billing NPI 1063632826) in the available physician profile data.

Does Jeffery Scott Davis, APN RN have Open Payments data?

Jeffery Scott Davis, APN RN has 104 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.